EA
SCMP

Emerald Acquisition’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Emerald Acquisition’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-97,968
Closed -$1.07M – 3112
2016
Q2 		$1.07M Buy
+97,968
New +$1.1M ﹤0.01% 2132

Other funds holding SCMP

LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Emerald Acquisition's SCMP Position: Q3 2016 in Review

Emerald Acquisition sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q3 2016, closing a stake of 97,968 shares — an estimated $1.07M sold.

Emerald Acquisition first reported a position in SCMP in Q2 2016 and held it in 1 quarter. The position peaked at $1.07M in Q2 2016. 119 funds tracked by Wall St. Rank hold SCMP as of Q3 2016.

  • Emerald Acquisition reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Emerald Acquisition sold 97,968 Sucampo Pharmaceuticals, Inc. shares in Q3 2016, an estimated $1.07M.
  • Emerald Acquisition first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2016 and held it in 1 quarter.
  • Emerald Acquisition's Sucampo Pharmaceuticals, Inc. position peaked at $1.07M in Q2 2016.
  • 119 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.